Age-associated cognitive decline: Insights into molecular switches and recovery avenues

Aging and Disease

Volumn 7, Issue 2, 2016, Pages 121-129

  Konar, Arpita ^a,b   Singh, Padmanabh ^a   Thakur, Mahendra K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Brain aging; Cognitive decline; Gene expression; Molecular mechanism; Recovery

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DNA METHYLTRANSFERASE; ESTROGEN RECEPTOR; HISTONE DEACETYLASE 2; RALOXIFENE; SCOPOLAMINE; SEX HORMONE; TESTOSTERONE;

ALZHEIMER DISEASE; BRAIN FUNCTION; CELL AGING; CELL MIGRATION; COGNITIVE DEFECT; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURITE OUTGROWTH; NEUROBIOLOGY; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PREVALENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SYNAPTIC EFFICACY; TRANSCRIPTOMICS; WORKING MEMORY;

EID: 85026474129     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2015.1004     Document Type: Review

References (84)

1. Hedden T, Gabrieli JDE (2004). Insights into the aging mind: a view from cognitive neuroscience. Nat Rev Neurosci, 5:87-97.
2. Andrade C, Radhekrishan R (2009). The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments. Indian J Psychiatry, 51:12-25.
3. den Dunnen WF, Brouwer WH, et al (2008). No disease in the brain of a 115-year-old woman. Neurobiol Aging, 29:1127-32.
4. Nicolle MM, Gonzalez J, Sugaya K, et al (2001). Signatures of hippocampal oxidative stress in aged spatial learning-impaired rodents. Neuroscience, 107:415-31
5. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA (2004). Gene regulation and DNA damage in the ageing human brain. Nature, 429:883-91.
6. Loerch PM, Lu T, Dakin KA, et al (2008). Evolution of the aging brain transcriptome and synaptic regulation. PLoS One, 3(10):e3329
7. Yankner A, Lu T, Bruce LP (2008). The aging brain. Annu Rev Pathol Mech Dis, 3:41-66.
8. Berchtold NC, Cribbs DH, Coleman PD, et al (2008). Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci USA, 105:15605-10.
9. Zeier Z, Madorsky I, Xu Y, Ogle WO, Notterpek L, Foster TC (2011). Gene expression in the hippocampus: regionally specific effects of aging and caloric restriction. Mech Ageing Dev, 132:8-19.
10. Veiga S, Melcangib RC, DonCarlosc LL, Garcia-Seguraa LM, Azcoitiad I (2004). Sex hormones and brain aging. Exp Gerontol, 39:1623-31.
11. Thakur MK, Sharma PK (2006). Aging of brain: role of estrogen. Neurochem Res, 31:1389-98.
12. Mérot Y, Ferrière F, Debroas E, Flouriot G, Duval D, Saligaut C (2005). Estrogen receptor alpha mediates neuronal differentiation and neuroprotection in PC12 cells: critical role of the A/B domain of the receptor. J Mol Endocrinol, 35:257-67.
13. Ghosh S, Thakur MK (2009). Interaction of estrogen receptor-alpha ligand binding domain with nuclear proteins of aging mouse brain. J Neurosci Res, 87: 2591-600.
14. Kelly JF, Bienias JL, Shah A, Meeke KA, Schneider JA, Soriano E, Bennett DA (2008). Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. Curr Alzheimer Res, 10:45-51.
15. Mehra RD, Sharma K, Nyakas C, Vij U (2005). Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study. Brain Res, 1056:22-35.
16. Paramanik V, Thakur MK (2010). Interaction of estrogen receptor associated protein (ERAP) 140 with ER beta decreases but its expression increases in aging mouse cerebral cortex. Cell Mol Neurobiol, 30: 961-6.
17. Paramanik V, Thakur MK (2013). Role of CREB signaling in aging brain. Arch Ital Biol, 151:33-42.
18. Kindler J, Weickert CS, Skilleter AJ, Catts SV, Lenroot R, Weickert TW (2015). Selective estrogen receptor modulation increases hippocampal activity during probabilistic association learning in schizophrenia. Neuropsychopharmacology, 40:2388-97.
19. Diez-Perez A (2006). Selective estrogen receptor modulators (SERMS). Arq Bras Endocrinol Metab, 50: 720-34.
20. Draper MW, Flowers DE, Huster WJ, Neild JA, Harper KD, Arnaud C (1996). A controlled trial of Raloxifene (LY 139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res, 11:835-42.
21. Maximov PY, Lee TM, Jordan VC (2013). The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol, 8:135-55.
22. Sivanandam TM, Thakur MK (2011). Amyloid precursor protein (APP) mRNA level is higher in the old mouse cerebral cortex and is regulated by sex steroids. J Mol Neurosci, 43:235-40.
23. Ghosh S, Thakur MK (2008). PS1 expression is downregulated by gonadal steroids in adult mouse brain. Neurochem Res, 33:365-9.
24. Ghosh S, Thakur MK (2008). PS2 protein expression is upregulated by sex steroids in the cerebral cortex of aging mice. Neurochem Int, 52:363-367.
25. Mahley RW, Rall SC Jr (2000). Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet, 1:507-37.
26. Bales KR, Dodart JC, DeMattos RB, Holtzman DM, Paul SM (2002). Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv, 2:363-75.
27. Mahley RW, Weisgraber KH, Huang Y (2006). Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A, 103:5644-51.
28. Singh S, Thakur MK (2011). Age-dependent expression of apolipoprotein E in mouse cerebral cortex. J Mol Neurosci, 43(3):251-56.
29. Singh P, Thakur MK (2014). Reduced recognition memory is correlated with decrease in DNA methyltransferase1 and increase in histone deacetylase2 protein expression in old male mice. Biogerontology, 15:339-46.
30. Peleg S, Sananbenesi F, Zovoilis A, et al (2010). Altered histone acetylation is associated with age-dependent memory impairment in mice. Science, 328:753-6.
31. Smith DE, Rapp PR, McKay HM, Roberts JA, Tuszynski MH (2004). Memory impairment in aged primates is associated with focal death of cortical neurons and atrophy of subcortical neurons. J Neurosci, 24:4373-81.
32. Ystad MA, Lundervold AJ, Wehling E, et al (2009). Hippocampal volumes are important predictors for memory function in elderly women. BMC Med Imaging, 9:17.
33. Brickman AM, Stern Y (2009). Aging and memory in humans. Vol. 1. In: Squire LR, editor. Encyclopedia of Neuroscience. Elsevier Ltd, 175-80.
34. Morrison JH, Baxter MG (2012). The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci, 13:240-50.
35. Barrientos RM, Frank MG, Watkins LR, Maier SF (2012). Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition. Horm Behav, 62:219-27.
36. Chen ZL, Yoshida S, Kato K, Momota Y, et al (1995). Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci, 75:5088-97.
37. Suzuki J, Yoshida S, Chen ZL, Momota Y, Kato K, Hirata A, Shiosaka S (1995). Ontogeny of neuropsin mRNA expression in the mouse brain. Neurosci Res, 23:345-51.
38. Yousef GM, Diamandis EP (2001). The new human tissue kallikrein gene family: structure, function and association to disease. Endocr Rev, 22:184-204.
39. Matsumoto-Miyai K, Ninomiya A, Yamasaki H, Tamura H, Nakamura Y, Shiosaka S (2003). NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin. J Neurosci, 23:7727-36.
40. Poplawski GHD, Tranziska AK, Leshchyns'ka I, et al (2012). L1CAM increases MAP2 expression via the MAPK pathway to promote neurite outgrowth. Mol Cell Neurosci, 50:169-78.
41. Konar A, Thakur MK (2015). Neuropsin expression correlates with dendritic marker MAP2c level in different brain regions of aging mice. Mol Neurobiol, 51:1130-38.
42. Kumari A, Thakur MK (2014). Age-dependent decline of nogo-a protein in the mouse cerebrum. Cell Mol Neurobiol, 34:1131-41.
43. Yamagata M, Sanes JR, Weiner JA (2003). Synaptic adhesion molecules. Curr Opin Cell Biol, 15:621-32.
44. Budreck EC, Scheiffele P (2007). Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. Eur J Neurosci, 26:1738-48.
45. Krueger DD, Tuffy LP, Papadopoulos T, Brose N (2012). The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr Opin Neurobiol, 22:412-22.
46. Kumar D, Thakur MK (2015). Age-related expression of Neurexin1 and Neuroligin3 is correlated with presynaptic density in the cerebral cortex and hippocampus of male mice. Age, 37:17
47. Lubin FD, Roth TL, Sweatt JD (2008). Epigenetic regulation of bdnf gene transcription in the consolidation of fear memory. J Neurosci, 28: 10576-86.
48. Chouliaras L, Mastroeni D, Delvaux E, et al (2013). Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging, 34:2091-99.
49. Richardson B (2003). Impact of aging on DNA methylation. Ageing Res Rev. 2: 245-61.
50. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J (2011). Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging, 32:1161-80.
51. Mastroeni D, Chouliaras L, Grover A, Liang WS, Hauns K, Rogers J, Coleman PD (2013). Reduced RAN expression and disrupted transport between cytoplasm and nucleus; a key event in Alzheimer's disease pathophysiology. PLoS One, 8(1):e53349.
52. Penner MR, Roth TL, Chawla MK, Hoang LT, Roth ED, Lubin FD, Sweatt JD, Worley PF, Barnes CA (2011). Age-related changes in Arc transcription and DNA methylation within the hippocampus. Neurobiol Aging, 32:2198-210.
53. Nagata T, Kobayashi N, Ishii J, et al (2015). Association between DNA methylation of the BDNF promoter region and clinical presentation in Alzheimer's disease. Dement Geriatr Cogn Dis Extra, 5:64-73.
54. Zhang Y, Qian YP, Jiang KD, Yu SY, Wang DX, Zhang MY, Jiang SD (2006). Expression levels of APP and PS1 genes in patients with Alzheimer's Disease. Yi Chuan, 28:525-8.
55. Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Genda Y, Ukitsu M (1999). Reduction with age in methylcytosine in the promoter region-224 approximately-101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res Mol Brain Res, 70:288-92.
56. Li E, Bestor TH, Jaenisch R (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69:915-26.
57. Golshani P, Hutnick L, Schweizer F, Fan G (2005). Conditional Dnmt1 deletion in dorsal forebrain disrupts development of somatosensory barrel cortex and thalamocortical long-term potentiation. Thalamus Relat Syst, 3:227-33.
58. Hutnick LK, Golshani P, Namihira M, et al (2009). DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Hum Mol Genet, 18:2875-88.
59. Feng J, Zhou Y, Campbell SL, et al (2010). Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci, 13: 423-30.
60. Liu L, Groen TV, Kadish I, et al (2011). Insufficient DNA methylation affects healthy aging and promotes age-related health problems. Clin Epigenetics, 2: 349-60.
61. Klein CJ, Botuyan MV, Wu Y, et al (2011). Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet, 43:595-600.
62. Kanungo MS, Thakur MK (1979). Modulation of acetylation of histones and transcription of chromatin by butyric acid and 17β-estradiol in the brain of rats of various ages. Biochem Biophys Res Commun, 87:266-71.
63. Kanungo MS & Thakur MK (1977) Phosphorylation of chromosomal proteins as a function of age and its modulation by calcium. Biochem Biophys Res Commun 79:1031-6.
64. Thakur MK, Kanungo MS (1981). Methylation of chromosomal proteins and DNA of rat brain and its modulation by estradiol and calcium during aging. Exp Gerontol, 16:331-7.
65. Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai LH (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature, 447:178-82.
66. Pavlopoulos E, Jones S, Kosmidis S, Close M, Kim C, Kovalerchik O, Small SA, Kandel ER (2013). Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med, 5:200ra115
67. Singh P, Konar A, Kumar A, Srivas S, Thakur MK (2015). Hippocampal chromatin modifying enzymes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment. J Neurochem, 134:642-51
68. Guan JS, Haggarty SJ, Giacometti E, et al (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature, 459:55-60.
69. Gräff J, Rei D, Guan JS, Wang WY, et al (2012). An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature, 483:222-6.
70. Kim SE, Ko IG, Kim BK, et al (2010). Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus. Exp Gerontol, 45:357-65.
71. Kuzumaki N, Ikegami D, Tamura R, et al (2010). Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging. Synapse, 64:611-6.
72. Thakur MK, Konar A (2014). Brain Aging and associated diseases-Text book on geriatric medicine. In: Sanchetee P, editor. Indian academy of geriatrics. Hyderabad: Paras Medical Publisher, 32-36
73. Thakur MK, Konar A, Gautam A (2012). Brain Aging: A Critical Reappraisal. In: Thakur MK and Rattan SIS, editors. Brain Aging and Therapeutic Interventions. Auckland: Springer, 1-18.
74. Intlekofer KA, Berchtold NC, Malvaez M, et al (2013). Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism. Neuropsychopharmacology, 38:2027-34.
75. Reolon GK, Maurmann N, Werenicz A, et al (2011). Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats. Behav Brain Res, 221:329-32.
76. Yoo DY, Kim W, Lee CH, Shin BN, Nam SM, Choi JH, Won MH, Yoon YS, Hwang IK (2012). Melatonin improves D-galactose-induced aging effects on behavior, neurogenesis, and lipid peroxidation in the mouse dentate gyrus via increasing pCREB expression. J Pineal Res, 52:21-8.
77. Kilgore M, Miller CA, Fass DM, et al (2010). Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology. 35:870-80.
78. Abel T, Zukin RS (2008). Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol. 8:57-64.
79. Subramanian S, Bates SE, Wright JJ, Espinoza-Delgado I, Piekarz RL (2010) Clinical toxicities of histone deacetylase inhibitors, 3:2751-67.
80. Kazantsev AG, Thompson LM (2008). Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov, 7:854-68.
81. Sigfrido Scarpa, Andrea Fuso, Fabrizio D'Anselmi, Rosaria A Cavallaro (2003). Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Letter, 541:145-8.
82. Shea TB, Rogers E, Ashline D, Ortiz D, Sheu MS (2002). Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med. 33:1115-20.
83. Mihalick SM, Ortiz D, Kumar R, Rogers E, Shea TB (2003). Folate and vitamin E deficiency impair cognitive performance in mice subjected to oxidative stress: differential impact on normal mice and mice lacking apolipoprotein E. Neuromolecular Med, 4:197-202.
84. Tchantchou F, Graves M, Ortiz D, Chan A, Rogers E, Shea TB (2006). S-adenosyl methionine: A connection between nutritional and genetic risk factors for neurodegeneration in Alzheimer's disease. J Nutr Health Aging, 10:541-4.